{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T07:13:20Z","timestamp":1775978000163,"version":"3.50.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 110-2320-B-039-030-MY3"],"award-info":[{"award-number":["MOST 110-2320-B-039-030-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-110-047"],"award-info":[{"award-number":["DMR-110-047"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital","doi-asserted-by":"publisher","award":["DMR-110-0047"],"award-info":[{"award-number":["DMR-110-0047"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007300","name":"China Medical University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007300","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Taichung Tzu Chi Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogenesis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Migration and metastasis commonly happen to triple-negative breast cancer (TNBC) patients with advanced diseases. In many studies, it has been suggested that epithelial-mesenchymal transition (EMT) is one of the key mechanisms triggering cancer metastasis. Accumulating evidence has proven that calcium channel blockers mediate cell motility. Therefore, we attempt to investigate the effects of diltiazem, which has been selected from several FDA-approved clinical calcium channel blockers, on EMT in TNBC. By using both mouse and human TNBC cell lines, we found that diltiazem decreases colony formation and cell migration in breast cancer cells. The expression of epithelial markers such as E-cadherin and ZO-1 were increased dose-dependently by diltiazem, while mesenchymal markers such as Snail and Twist were decreased. In addition, we found that the expression of growth differentiation factor-15 (GDF-15) was also increased by diltiazem. Administering recombinant GDF-15 also reverses EMT, inhibits colony formation and migration in breast cancer cells. Moreover, treatment with diltiazem in tumor-bearing mice also decreases cancer metastasis and nodule formation, with more GDF-15 expression in diltiazem-treated mice than saline-treated mice, respectively. These findings suggest that diltiazem regulates EMT and cell motility through elevating GDF-15 expression in breast cancers in vitro and in vivo.<\/jats:p>","DOI":"10.1038\/s41389-022-00423-5","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T11:02:49Z","timestamp":1660388569000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Diltiazem inhibits breast cancer metastasis via mediating growth differentiation factor 15 and epithelial-mesenchymal transition"],"prefix":"10.1038","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2214-8992","authenticated-orcid":false,"given":"Yen-Chang","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Teng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Fang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Yun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Chun","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4398-7610","authenticated-orcid":false,"given":"Wei-Lan","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,13]]},"reference":[{"key":"423_CR1","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331:1559\u201364.","journal-title":"Science"},{"key":"423_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40880-017-0206-7","volume":"36","author":"C-N Qian","year":"2017","unstructured":"Qian C-N, Mei Y, Zhang J. Cancer metastasis: issues and challenges. Chin J Cancer. 2017;36:1\u20134.","journal-title":"Chin J Cancer"},{"key":"423_CR3","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1080\/15384047.2018.1456599","volume":"19","author":"L Jin","year":"2018","unstructured":"Jin L, Han B, Siegel E, Cui Y, Giuliano A, Cui X. Breast cancer lung metastasis: Molecular biology and therapeutic implications. Cancer Biol Ther. 2018;19:858\u201368.","journal-title":"Cancer Biol Ther"},{"key":"423_CR4","first-page":"311","volume":"9","author":"OJ Scully","year":"2012","unstructured":"Scully OJ, Bay B-H, Yip G, Yu Y. Breast cancer metastasis. Cancer Genomics Proteom. 2012;9:311\u201320.","journal-title":"Cancer Genomics Proteom"},{"key":"423_CR5","doi-asserted-by":"publisher","first-page":"5652","DOI":"10.1200\/JCO.2006.06.5664","volume":"24","author":"BG Haffty","year":"2006","unstructured":"Haffty BG, Yang Q, Reiss M, Kearney T, Higgins SA, Weidhaas J, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol: Off J Am Soc Clin Oncol. 2006;24:5652\u20137.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"423_CR6","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1002\/cncr.23930","volume":"113","author":"NU Lin","year":"2008","unstructured":"Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP. Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer. 2008;113:2638\u201345.","journal-title":"Cancer"},{"key":"423_CR7","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1200\/JCO.2007.14.4287","volume":"26","author":"PL Nguyen","year":"2008","unstructured":"Nguyen PL, Taghian AG, Katz MS, Niemierko A, Abi Raad RF, Boon WL, et al. Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol: Off J Am Soc Clin Oncol. 2008;26:2373\u20138.","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"423_CR8","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1038\/nature22816","volume":"547","author":"X Ye","year":"2017","unstructured":"Ye X, Brabletz T, Kang Y, Longmore GD, Nieto MA, Stanger BZ, et al. Upholding a role for EMT in breast cancer metastasis. Nature. 2017;547:E1\u2013E3.","journal-title":"Nature"},{"key":"423_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial\u2013mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178\u201396.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"423_CR10","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1002\/ptr.6071","volume":"32","author":"Y Ci","year":"2018","unstructured":"Ci Y, Zhang Y, Liu Y, Lu S, Cao J, Li H, et al. Myricetin suppresses breast cancer metastasis through down\u2010regulating the activity of matrix metalloproteinase (MMP)\u20102\/9. Phytother Res. 2018;32:1373\u201381.","journal-title":"Phytother Res"},{"key":"423_CR11","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1349-7006.2011.01861.x","volume":"102","author":"CY Lin","year":"2011","unstructured":"Lin CY, Tsai PH, Kandaswami CC, Lee PP, Huang CJ, Hwang JJ, et al. Matrix metalloproteinase-9 cooperates with transcription factor Snail to induce epithelial-mesenchymal transition. Cancer Sci. 2011;102:815\u201327.","journal-title":"Cancer Sci"},{"key":"423_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-18101-7","volume":"7","author":"WS Wu","year":"2017","unstructured":"Wu WS, You RI, Cheng CC, Lee MC, Lin TY, Hu CT. Snail collaborates with EGR-1 and SP-1 to directly activate transcription of MMP 9 and ZEB1. Sci Rep. 2017;7:17753.","journal-title":"Sci Rep"},{"key":"423_CR13","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.3389\/fphys.2018.01712","volume":"9","author":"PJ Emmerson","year":"2018","unstructured":"Emmerson PJ, Duffin KL, Chintharlapalli S, Wu X. GDF15 and growth control. Front Physiol. 2018;9:1712.","journal-title":"Front Physiol"},{"key":"423_CR14","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","volume":"11","author":"J Wischhusen","year":"2020","unstructured":"Wischhusen J, Melero I, Fridman WH. Growth\/differentiation factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front Immunol. 2020;11:951.","journal-title":"Front Immunol"},{"key":"423_CR15","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm.4394","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang L, Chang C-C, Sun Z, Madsen D, Zhu H, Padkj\u00e6r SB, et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med. 2017;23:1158\u201366.","journal-title":"Nat Med"},{"key":"423_CR16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.2174\/1381612825666190402101143","volume":"25","author":"L Fang","year":"2019","unstructured":"Fang L, Li F, Gu C. GDF-15: a multifunctional modulator and potential therapeutic target in cancer. Curr Pharm Des. 2019;25:654\u201362.","journal-title":"Curr Pharm Des"},{"key":"423_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.omtn.2018.05.016","volume":"12","author":"X Lu","year":"2018","unstructured":"Lu X, He X, Su J, Wang J, Liu X, Xu K, et al. EZH2-mediated epigenetic suppression of GDF15 predicts a poor prognosis and regulates cell proliferation in non-small-cell lung cancer. Mol Ther Nucleic Acids. 2018;12:309\u201318.","journal-title":"Mol Ther Nucleic Acids"},{"key":"423_CR18","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1080\/21691401.2018.1466146","volume":"46","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Wang X, Zhang M, Zhang Z, Jiang L, Li L. GDF15 promotes epithelial-to-mesenchymal transition in colorectal [corrected]. Artif Cells Nanomed Biotechnol. 2018;46:652\u20138.","journal-title":"Artif Cells Nanomed Biotechnol"},{"key":"423_CR19","unstructured":"Talreja O, Cassagnol M. Diltiazem. Treasure Island (FL): StatPearls Publishing: (2021). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532937\/."},{"key":"423_CR20","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.2147\/CMAR.S228718","volume":"12","author":"B-S Wong","year":"2020","unstructured":"Wong B-S, Chiu L-Y, Tu D-G, Sheu G-T, Chan T-T. Anticancer effects of antihypertensive L-type calcium channel blockers on chemoresistant lung cancer cells via autophagy and apoptosis. Cancer Manag Res. 2020;12:1913.","journal-title":"Cancer Manag Res"},{"key":"423_CR21","first-page":"1","volume":"110","author":"MA Alqudah","year":"2017","unstructured":"Alqudah MA, Alrababah BA, Mhaidat NM. Amlodipine inhibits cell proliferation and induces cell cycle arrest in colorectal cancer cells. Jordan J Pharm Sci. 2017;110:1\u20138.","journal-title":"Jordan J Pharm Sci"},{"key":"423_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12935-019-0912-0","volume":"19","author":"HS Al-Malky","year":"2019","unstructured":"Al-Malky HS, Osman A-MM, Damanhouri ZA, Alkreathy HM, Al Aama JY, Ramadan WS, et al. Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals. Cancer Cell Int. 2019;19:1\u201310.","journal-title":"Cancer Cell Int"},{"key":"423_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.toxlet.2009.11.018","volume":"192","author":"L-Y Chiu","year":"2010","unstructured":"Chiu L-Y, Ko J-L, Lee Y-J, Yang T-Y, Tee Y-T, Sheu G-T. L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines. Toxicol Lett. 2010;192:408\u201318.","journal-title":"Toxicol Lett"},{"key":"423_CR24","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.canlet.2009.02.034","volume":"284","author":"P Jiang","year":"2009","unstructured":"Jiang P, Enomoto A, Takahashi M. Cell biology of the movement of breast cancer cells: intracellular signalling and the actin cytoskeleton. Cancer Lett. 2009;284:122\u201330.","journal-title":"Cancer Lett"},{"key":"423_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/bcr3585","volume":"15","author":"K Van Impe","year":"2013","unstructured":"Van Impe K, Bethuyne J, Cool S, Impens F, Ruano-Gallego D, De Wever O, et al. A nanobody targeting the F-actin capping protein CapG restrains breast cancer metastasis. Breast Cancer Res. 2013;15:1\u201315.","journal-title":"Breast Cancer Res"},{"key":"423_CR26","doi-asserted-by":"publisher","first-page":"8323","DOI":"10.3390\/ijms21218323","volume":"21","author":"S Patergnani","year":"2020","unstructured":"Patergnani S, Danese A, Bouhamida E, Aguiari G, Previati M, Pinton P, et al. Various aspects of calcium signaling in the regulation of apoptosis, autophagy, cell proliferation, and cancer. Int J Mol Sci. 2020;21:8323.","journal-title":"Int J Mol Sci"},{"key":"423_CR27","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/S0140-6736(05)64695-8","volume":"348","author":"L Hardell","year":"1996","unstructured":"Hardell L, Axelson O, Fredrikson M. Antihypertensive drugs and risk of malignant diseases. Lancet. 1996;348:542.","journal-title":"Lancet"},{"key":"423_CR28","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(96)24034-6","volume":"348","author":"NM Kaplan","year":"1996","unstructured":"Kaplan NM. Do calcium antagonists cause cancer? Lancet. 1996;348:541\u20132.","journal-title":"Lancet"},{"key":"423_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(96)04277-8","volume":"348","author":"M Pahor","year":"1996","unstructured":"Pahor M, Guralnik JM, Ferrucci L, Corti MC, Salive ME, Cerhan JR, et al. Calcium-channel blockade and incidence of cancer in aged populations. Lancet. 1996;348:493\u20137.","journal-title":"Lancet"},{"key":"423_CR30","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0895-7061(96)00186-0","volume":"9","author":"M Pahor","year":"1996","unstructured":"Pahor M, Guralnik JM, Salive ME, Corti MC, Carbonin P, Havlik RJ. Do calcium channel blockers increase the risk of cancer? Am J Hypertens. 1996;9:695\u20139.","journal-title":"Am J Hypertens"},{"key":"423_CR31","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/BF01142195","volume":"2","author":"AC Durham","year":"1982","unstructured":"Durham AC, Walton JM. Calcium ions and the control of proliferation in normal and cancer cells. Biosci Rep. 1982;2:15\u201330.","journal-title":"Biosci Rep"},{"key":"423_CR32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1096\/fasebj.9.2.7781924","volume":"9","author":"BF Trump","year":"1995","unstructured":"Trump BF, Berezesky IK. Calcium-mediated cell injury and cell death. FASEB J. 1995;9:219\u201328.","journal-title":"FASEB J"},{"key":"423_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0140-6736(05)64362-0","volume":"348","author":"R Horton","year":"1996","unstructured":"Horton R. Do calcium antagonists cause cancer? Lancet. 1996;348:49.","journal-title":"Lancet"},{"key":"423_CR34","doi-asserted-by":"publisher","first-page":"e009147","DOI":"10.1136\/bmjopen-2015-009147","volume":"6","author":"L Grimaldi-Bensouda","year":"2016","unstructured":"Grimaldi-Bensouda L, Klungel O, Kurz X, de Groot MC, Maciel Afonso AS, de Bruin ML, et al. Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD). BMJ Open. 2016;6:e009147.","journal-title":"BMJ Open"},{"key":"423_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0720-6","volume":"18","author":"LE Wilson","year":"2016","unstructured":"Wilson LE, D\u2019Aloisio AA, Sandler DP, Taylor JA. Long-term use of calcium channel blocking drugs and breast cancer risk in a prospective cohort of US and Puerto Rican women. Breast Cancer Res. 2016;18:61.","journal-title":"Breast Cancer Res"},{"key":"423_CR36","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s00249-016-1144-z","volume":"45","author":"PJ Buchanan","year":"2016","unstructured":"Buchanan PJ, McCloskey KD. Ca V channels and cancer: canonical functions indicate benefits of repurposed drugs as cancer therapeutics. Eur Biophysics J. 2016;45:621\u201333.","journal-title":"Eur Biophysics J"},{"key":"423_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.apsb.2016.11.001","volume":"7","author":"C Cui","year":"2017","unstructured":"Cui C, Merritt R, Fu L, Pan Z. Targeting calcium signaling in cancer therapy. Acta Pharmaceutica Sin B. 2017;7:3\u201317.","journal-title":"Acta Pharmaceutica Sin B"},{"key":"423_CR38","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/0022-202X(89)90051-1","volume":"93","author":"W Diezel","year":"1989","unstructured":"Diezel W, Gruner S, Diaz LA, Anhalt GJ. Inhibition of cutaneous contact hypersensitivity by calcium transport inhibitors lanthanum and diltiazem. J Investigative Dermatol. 1989;93:322\u20136.","journal-title":"J Investigative Dermatol"},{"key":"423_CR39","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1038\/sj.cdd.4401105","volume":"9","author":"M Donovan","year":"2002","unstructured":"Donovan M, Cotter T. Caspase-independent photoreceptor apoptosis in vivo and differential expression of apoptotic protease activating factor-1 and caspase-3 during retinal development. Cell Death Differ. 2002;9:1220\u201331.","journal-title":"Cell Death Differ"},{"key":"423_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.ejheart.2005.07.012","volume":"8","author":"D Westermann","year":"2006","unstructured":"Westermann D, Knollmann BC, Steendijk P, Rutschow S, Riad A, Pauschinger M, et al. Diltiazem treatment prevents diastolic heart failure in mice with familial hypertrophic cardiomyopathy. Eur J Heart Fail. 2006;8:115\u201321.","journal-title":"Eur J Heart Fail"},{"key":"423_CR41","doi-asserted-by":"publisher","first-page":"12279","DOI":"10.1074\/jbc.M109.086405","volume":"285","author":"J Wang","year":"2010","unstructured":"Wang J, Peng Q, Lin Q, Childress C, Carey D, Yang W. Calcium activates Nedd4 E3 ubiquitin ligases by releasing the C2 domain-mediated auto-inhibition. J Biol Chem. 2010;285:12279\u201388.","journal-title":"J Biol Chem"},{"key":"423_CR42","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.bbamcr.2017.03.001","volume":"1864","author":"R Mukherjee","year":"2017","unstructured":"Mukherjee R, Das A, Chakrabarti S, Chakrabarti O. Calcium dependent regulation of protein ubiquitination - Interplay between E3 ligases and calcium binding proteins. Biochimica et Biophysica Acta Mol Cell Res. 2017;1864:1227\u201335.","journal-title":"Biochimica et Biophysica Acta Mol Cell Res"},{"key":"423_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1091\/mbc.e11-07-0623","volume":"23","author":"M Yazaki","year":"2012","unstructured":"Yazaki M, Kashiwagi K, Aritake K, Urade Y, Fujimori K. Rapid degradation of cyclooxygenase-1 and hematopoietic prostaglandin D synthase through ubiquitin-proteasome system in response to intracellular calcium level. Mol Biol Cell. 2012;23:12\u201321.","journal-title":"Mol Biol Cell"},{"key":"423_CR44","doi-asserted-by":"publisher","first-page":"490842","DOI":"10.1155\/2015\/490842","volume":"2015","author":"R Adela","year":"2015","unstructured":"Adela R, Banerjee SK. GDF-15 as a target and biomarker for diabetes and cardiovascular diseases: a translational prospective. J Diabetes Res. 2015;2015:490842.","journal-title":"J Diabetes Res"},{"key":"423_CR45","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1038\/nm.4392","volume":"23","author":"SE Mullican","year":"2017","unstructured":"Mullican SE, Lin-Schmidt X, Chin C-N, Chavez JA, Furman JL, Armstrong AA, et al. GFRAL is the receptor for GDF15 and the ligand promotes weight loss in mice and nonhuman primates. Nat Med. 2017;23:1150\u20137.","journal-title":"Nat Med"},{"key":"423_CR46","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1165\/rcmb.2018-0379TR","volume":"60","author":"FM Verhamme","year":"2019","unstructured":"Verhamme FM, Freeman CM, Brusselle GG, Bracke KR, Curtis JL. GDF-15 in pulmonary and critical care medicine. Am J Respiratory Cell Mol Biol. 2019;60:621\u20138.","journal-title":"Am J Respiratory Cell Mol Biol"},{"key":"423_CR47","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/nm.4414","volume":"23","author":"I Cimino","year":"2017","unstructured":"Cimino I, Coll AP, Yeo GS. GDF15 and energy balance: homing in on a mechanism. Nat Med. 2017;23:1119\u201320.","journal-title":"Nat Med"},{"key":"423_CR48","doi-asserted-by":"publisher","first-page":"103557","DOI":"10.18632\/oncotarget.21581","volume":"8","author":"M Han","year":"2017","unstructured":"Han M, Dai D, Yousafzai NA, Wang F, Wang H, Zhou Q, et al. CXXC4 activates apoptosis through up-regulating GDF15 in gastric cancer. Oncotarget. 2017;8:103557.","journal-title":"Oncotarget"},{"key":"423_CR49","doi-asserted-by":"publisher","first-page":"860","DOI":"10.18632\/oncotarget.6205","volume":"7","author":"C Li","year":"2016","unstructured":"Li C, Wang J, Kong J, Tang J, Wu Y, Xu E, et al. GDF15 promotes EMT and metastasis in colorectal cancer. Oncotarget. 2016;7:860.","journal-title":"Oncotarget"},{"key":"423_CR50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-017-0664-4","volume":"37","author":"S Li","year":"2018","unstructured":"Li S, Ma Y-M, Zheng P-S, Zhang P. GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1\/2 through the receptor ErbB2. J Exp Clin Cancer Res. 2018;37:1\u201314.","journal-title":"J Exp Clin Cancer Res"},{"key":"423_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-37425-6","volume":"9","author":"M Kalli","year":"2019","unstructured":"Kalli M, Minia A, Pliaka V, Fotis C, Alexopoulos LG, Stylianopoulos T. Solid stress-induced migration is mediated by GDF15 through Akt pathway activation in pancreatic cancer cells. Sci Rep. 2019;9:1\u201312.","journal-title":"Sci Rep"},{"key":"423_CR52","doi-asserted-by":"publisher","first-page":"e3036","DOI":"10.1038\/cddis.2017.434","volume":"8","author":"Y Lu","year":"2017","unstructured":"Lu Y, Ma J, Li Y, Huang J, Zhang S, Yin Z, et al. CDP138 silencing inhibits TGF-\u03b2\/Smad signaling to impair radioresistance and metastasis via GDF15 in lung cancer. Cell Death Dis. 2017;8:e3036\u2013e3036.","journal-title":"Cell Death Dis"},{"key":"423_CR53","doi-asserted-by":"publisher","first-page":"113964","DOI":"10.1016\/j.jep.2021.113964","volume":"273","author":"D Guo","year":"2021","unstructured":"Guo D, Guo C, Fang L, Sang T, Wang Y, Wu K, et al. Qizhen capsule inhibits colorectal cancer by inducing NAG-1\/GDF15 expression that mediated via MAPK\/ERK activation. J Ethnopharmacol. 2021;273:113964.","journal-title":"J Ethnopharmacol"},{"key":"423_CR54","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/pcan.2012.6","volume":"15","author":"P Va\u0148hara","year":"2012","unstructured":"Va\u0148hara P, Hampl A, Kozub\u00edk A, Sou\u010dek K. Growth\/differentiation factor-15: prostate cancer suppressor or promoter? Prostate Cancer Prostatic Dis. 2012;15:320\u20138.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"423_CR55","doi-asserted-by":"publisher","first-page":"1744","DOI":"10.1016\/j.bbadis.2018.02.020","volume":"1864","author":"T Wang","year":"2018","unstructured":"Wang T, Mao B, Cheng C, Zou Z, Gao J, Yang Y, et al. YAP promotes breast cancer metastasis by repressing growth differentiation factor-15. Biochimica et Biophysica Acta -Mol Basis Dis. 2018;1864:1744\u201353.","journal-title":"Biochimica et Biophysica Acta -Mol Basis Dis"},{"key":"423_CR56","first-page":"2379","volume":"41","author":"L Duan","year":"2019","unstructured":"Duan L, Pang HL, Chen WJ, Shen WW, Cao PP, Wang SM, et al. The role of GDF15 in bone metastasis of lung adenocarcinoma cells. Oncol Rep. 2019;41:2379\u201388.","journal-title":"Oncol Rep"},{"key":"423_CR57","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1124\/jpet.105.100081","volume":"318","author":"JM Martinez","year":"2006","unstructured":"Martinez JM, Sali T, Okazaki R, Anna C, Hollingshead M, Hose C, et al. Drug-induced expression of nonsteroidal anti-inflammatory drug-activated gene\/macrophage inhibitory cytokine-1\/prostate-derived factor, a putative tumor suppressor, inhibits tumor growth. J Pharmacol Exp Therapeutics. 2006;318:899\u2013906.","journal-title":"J Pharmacol Exp Therapeutics"},{"key":"423_CR58","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0378-1119(99)00309-1","volume":"237","author":"M Bottner","year":"1999","unstructured":"Bottner M, Laaff M, Schechinger B, Rappold G, Unsicker K, Suter-Crazzolara C. Characterization of the rat, mouse, and human genes of growth\/differentiation factor-15\/macrophage inhibiting cytokine-1 (GDF-15\/MIC-1). Gene. 1999;237:105\u201311.","journal-title":"Gene"},{"key":"423_CR59","doi-asserted-by":"publisher","first-page":"e1004890","DOI":"10.1371\/journal.pgen.1004890","volume":"10","author":"JC Ulirsch","year":"2014","unstructured":"Ulirsch JC, Lacy JN, An X, Mohandas N, Mikkelsen TS, Sankaran VG. Altered chromatin occupancy of master regulators underlies evolutionary divergence in the transcriptional landscape of erythroid differentiation. PLoS Genet. 2014;10:e1004890","journal-title":"PLoS Genet"},{"key":"423_CR60","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nm.4393","volume":"23","author":"PJ Emmerson","year":"2017","unstructured":"Emmerson PJ, Wang F, Du Y, Liu Q, Pickard RT, Gonciarz MD, et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med. 2017;23:1215\u20139.","journal-title":"Nat Med"},{"key":"423_CR61","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nature24042","volume":"550","author":"JY Hsu","year":"2017","unstructured":"Hsu JY, Crawley S, Chen M, Ayupova DA, Lindhout DA, Higbee J, et al. Non-homeostatic body weight regulation through a brainstem-restricted receptor for GDF15. Nature. 2017;550:255\u20139.","journal-title":"Nature"},{"key":"423_CR62","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.tem.2018.05.002","volume":"29","author":"SE Mullican","year":"2018","unstructured":"Mullican SE, Rangwala SM. Uniting GDF15 and GFRAL: therapeutic opportunities in obesity and beyond. Trends Endocrinol Metab: TEM. 2018;29:560\u201370.","journal-title":"Trends Endocrinol Metab: TEM"},{"key":"423_CR63","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.3390\/cells10112990","volume":"10","author":"K Johann","year":"2021","unstructured":"Johann K, Kleinert M, Klaus S. The role of GDF15 as a myomitokine. Cells. 2021;10:2990.","journal-title":"Cells"},{"key":"423_CR64","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/onc.2015.95","volume":"35","author":"KW Min","year":"2016","unstructured":"Min KW, Liggett JL, Silva G, Wu WW, Wang R, Shen RF, et al. NAG-1\/GDF15 accumulates in the nucleus and modulates transcriptional regulation of the Smad pathway. Oncogene. 2016;35:377\u201388.","journal-title":"Oncogene"},{"key":"423_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-022-00972-z","volume":"8","author":"W Zhang","year":"2022","unstructured":"Zhang W, Sun W, Gu X, Miao C, Feng L, Shen Q, et al. GDF-15 in tumor-derived exosomes promotes muscle atrophy via Bcl-2\/caspase-3 pathway. Cell Death Discov. 2022;8:162.","journal-title":"Cell Death Discov"},{"key":"423_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13039-020-00524-z","volume":"14","author":"S Azawi","year":"2021","unstructured":"Azawi S, Rincic M, Liehr T. Cytogenomic characteristics of murine breast cancer cell line JC. Mol Cytogenetics. 2021;14:7.","journal-title":"Mol Cytogenetics"},{"key":"423_CR67","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.fct.2018.07.059","volume":"120","author":"C-F Tsai","year":"2018","unstructured":"Tsai C-F, Chen J-H, Chang C-N, Lu D-Y, Chang P-C, Wang S-L, et al. Fisetin inhibits cell migration via inducing HO-1 and reducing MMPs expression in breast cancer cell lines. Food Chem Toxicol. 2018;120:528\u201335.","journal-title":"Food Chem Toxicol"}],"container-title":["Oncogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41389-022-00423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-022-00423-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41389-022-00423-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T19:17:41Z","timestamp":1669231061000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41389-022-00423-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,13]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["423"],"URL":"https:\/\/doi.org\/10.1038\/s41389-022-00423-5","relation":{},"ISSN":["2157-9024"],"issn-type":[{"value":"2157-9024","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,13]]},"assertion":[{"value":"28 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"48"}}